13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market
13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
  1. Home
  2. Insider Trading
  3. Hack Andrew A. F.

Hack Andrew A. F.

CIK: 0001657434
Director
Primary company: Editas Medicine, Inc. (EDIT)

Hack Andrew A. F. is a corporate insider at Editas Medicine, Inc. (EDIT) filing SEC Form 4 transactions. 151 transactions across 7 companies, totaling $76,850,773 in purchases and $335,360,102 in sales. Source: SEC EDGAR.

Total Transactions
151
Total Buy Value
$76.85M
Total Sell Value
$335.36M
Net Activity
$-258.51M
Last Transaction
Jun 2025
Companies
7

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Company
Type
Shares
Price
Value
Shares After
Date
SEC
Mersana Therapeutics, Inc.
MRSN
Award61,500--61,500
6/12/2025
Filed: 6/13/2025
Filing →
Nuvalent, Inc.
NUVL
Sale1,250,000$88.00$110.00M1,447,267
12/11/2024
Filed: 12/13/2024
Filing →
Nuvalent, Inc.
NUVL
Award3,789--3,789
6/12/2024
Filed: 6/14/2024
Filing →
Nuvalent, Inc.
NUVL
Award2,499--2,499
6/12/2024
Filed: 6/14/2024
Filing →
Mersana Therapeutics, Inc.
MRSN
Award55,000--55,000
6/11/2024
Filed: 6/12/2024
Filing →
Nuvalent, Inc.
NUVL
Sale791,795$72.31$57.25M2,697,267
3/27/2024
Filed: 3/29/2024
Filing →
Nuvalent, Inc.
NUVL
Sale88,205$76.88$6.78M3,489,062
3/27/2024
Filed: 3/29/2024
Filing →
DYNAVAX TECHNOLOGIES CORP
DVAX
Sale1,500,000$14.39$21.59M915,000
8/8/2023
Filed: 8/10/2023
Filing →
Nuvalent, Inc.
NUVL
Award15,000$0.00$015,000
6/15/2023
Filed: 6/16/2023
Filing →
DYNAVAX TECHNOLOGIES CORP
DVAX
Sale500,000$12.68$6.34M2,415,000
6/14/2023
Filed: 6/16/2023
Filing →
Mersana Therapeutics, Inc.
MRSN
Award18,355$0.00$018,355
6/8/2023
Filed: 6/12/2023
Filing →
Mersana Therapeutics, Inc.
MRSN
Award14,467$0.00$014,467
6/8/2023
Filed: 6/12/2023
Filing →
DYNAVAX TECHNOLOGIES CORP
DVAX
Award22,500$0.00$022,500
5/26/2023
Filed: 5/31/2023
Filing →
DYNAVAX TECHNOLOGIES CORP
DVAX
Award5,357$0.00$010,714
5/26/2023
Filed: 5/31/2023
Filing →
DYNAVAX TECHNOLOGIES CORP
DVAX
Sale1,000,000$10.55$10.55M2,915,000
5/18/2023
Filed: 5/19/2023
Filing →
DYNAVAX TECHNOLOGIES CORP
DVAX
Sale1,500,000$11.60$17.40M3,915,000
12/6/2022
Filed: 12/8/2022
Filing →
Nuvalent, Inc.
NUVL
Purchase149,253$33.50$5.00M3,577,267
11/3/2022
Filed: 11/3/2022
Filing →
DYNAVAX TECHNOLOGIES CORP
DVAX
Sale3,000,000$14.68$44.04M5,415,000
8/15/2022
Filed: 8/17/2022
Filing →
Nuvalent, Inc.
NUVL
Award20,000$0.00$020,000
6/16/2022
Filed: 6/17/2022
Filing →
Mersana Therapeutics, Inc.
MRSN
Award45,000$0.00$045,000
6/9/2022
Filed: 6/10/2022
Filing →
Mersana Therapeutics, Inc.
MRSN
Type
Award
Shares
61,500
Price
-
Value
-
Nuvalent, Inc.
NUVL
Type
Sale
Shares
1,250,000
Price
$88.00
Value
$110.00M
Nuvalent, Inc.
NUVL
Type
Award
Shares
3,789
Price
-
Value
-
Nuvalent, Inc.
NUVL
Type
Award
Shares
2,499
Price
-
Value
-
Mersana Therapeutics, Inc.
MRSN
Type
Award
Shares
55,000
Price
-
Value
-
Nuvalent, Inc.
NUVL
Type
Sale
Shares
791,795
Price
$72.31
Value
$57.25M
Nuvalent, Inc.
NUVL
Type
Sale
Shares
88,205
Price
$76.88
Value
$6.78M
DYNAVAX TECHNOLOGIES CORP
DVAX
Type
Sale
Shares
1,500,000
Price
$14.39
Value
$21.59M
Nuvalent, Inc.
NUVL
Type
Award
Shares
15,000
Price
$0.00
Value
$0
DYNAVAX TECHNOLOGIES CORP
DVAX
Type
Sale
Shares
500,000
Price
$12.68
Value
$6.34M
Mersana Therapeutics, Inc.
MRSN
Type
Award
Shares
18,355
Price
$0.00
Value
$0
Mersana Therapeutics, Inc.
MRSN
Type
Award
Shares
14,467
Price
$0.00
Value
$0
DYNAVAX TECHNOLOGIES CORP
DVAX
Type
Award
Shares
22,500
Price
$0.00
Value
$0
DYNAVAX TECHNOLOGIES CORP
DVAX
Type
Award
Shares
5,357
Price
$0.00
Value
$0
DYNAVAX TECHNOLOGIES CORP
DVAX
Type
Sale
Shares
1,000,000
Price
$10.55
Value
$10.55M
DYNAVAX TECHNOLOGIES CORP
DVAX
Type
Sale
Shares
1,500,000
Price
$11.60
Value
$17.40M
Nuvalent, Inc.
NUVL
Type
Purchase
Shares
149,253
Price
$33.50
Value
$5.00M
DYNAVAX TECHNOLOGIES CORP
DVAX
Type
Sale
Shares
3,000,000
Price
$14.68
Value
$44.04M
Nuvalent, Inc.
NUVL
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Mersana Therapeutics, Inc.
MRSN
Type
Award
Shares
45,000
Price
$0.00
Value
$0
...
AI Agent

Try asking...

FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market